Metraipolis › archive › dc_69b3fb665cbc
JAVEMACS-D: claims database analysis of avelumab maintenance therapy for advanced urothelial carcinoma in Japan — Europe PMC PMID:41290744
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41290744
- DOI
- 10.1038/s41598-[numero omesso]-1
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T17:15:11.080Z
- SHA-256 of the archived text
cfbef82bf99aea1faefa49f099fa893c8ab8a76affd54d3a587937833a580dff- Stable URL of this page
https://metraipolis.com/documento/dc_69b3fb665cbc
How to cite
JAVEMACS-D: claims database analysis of avelumab maintenance therapy for advanced urothelial carcinoma in Japan — Europe PMC PMID:41290744 — Europe PMC (en), https://europepmc.org/article/MED/41290744 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69b3fb665cbc (Metraipolis archive dc_69b3fb665cbc, sha256 cfbef82bf99aea1faefa49f099fa893c8ab8a76affd54d3a587937833a580dff)
BibTeX
@misc{dc69b3fb665cbc,
title = {JAVEMACS-D: claims database analysis of avelumab maintenance therapy for advanced urothelial carcinoma in Japan — Europe PMC PMID:41290744},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41290744},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69b3fb665cbc; sha256 cfbef82bf99aea1faefa49f099fa893c8ab8a76affd54d3a587937833a580dff},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41290744. Agents can read the archived copy with the MCP tool read_document.